Skip to main content

Table 3 Comparison of resistance rates between A.baumannii strains isolated from patients and from environmental samples to different products tested

From: In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: comparison between clinical and environmental isolates

Products Dilution Origin of the strains Total (n = 81) P
Patients (n = 45) Environment (n = 36)
PVPI PURE 0% (0) 0% (0) 0% (0) -
1|3 24.44% (11) 11.11% (4) 18.51% (15) 0.125
1|10 100% (45) 69.44% (25) 86.41%(70) <0.001
1|100, 1|1000 100% (45) 100% (36) 100% (81) -
CHX PURE 0% (0) 0% (0) 0% (0) -
1|10 13.33% (6) 0% (0) 7.40% (6) 0.31
1|100 51.11% (23) 66.66% (24) 58.02 (47) 0.159
1|1000 100% (45) 100% (36) 100% (81) -
AL PURE 0% (0) 0% (0) 0% (0) -
1|2 37.77% (17) 11.11% (4) 25.92% (21) 0.007
1|10 93.33% (42) 80.55% (29) 87.65% (71) 0.100
1|100, 1|1000 100%(45) 100% (36) 100% (81) -
DDA PURE, 1|10,1|100, 1|400 0% (0) 0% (0) 0% (0) -
1|1000 24.44% (11) 8.33% (3) 17.28% (14) 0.057
10–4 86.66% (39) 69.44% (25) 79.01% (64) 0.059
10–5, 10–6 100% (45) 100% (36) 100%(81) -
NRP PURE 24.44% (11) 0% (0) 13.58% (11) 0.001
1|10 66.66% (30) 19.44% (7) 45.67% (37) <0.001
1|50 97.77% (44) 94.44%(34) 96.29% (78) 0.582
1|100, 1|1000 100% (45) 100% (36) 100% (81) -
  1. PVPI povidone-iodine, CHX chlorhexidine digluconate, AL ethyl Alcohol, DDA N-(3-aminopropyl)-N-dodécylpropane-1,3-diamine + didecyl dimethyl ammonium chloride, NRP non registered
  2. - : p value not calculated